Clinical manifestations and inflammatory profiles in serum and skin of patients with neutrophilic dermatoses associated with adult onset immune deficiency due to autoantibodies to Interferon-gamma (IFN-γ)
- Conditions
- Clinical manifestations and inflammatory profiles in serum and skin of patients with neutrophilic dermatoses associated with adult onset immune deficiency due to autoantibodies to Interferon-gamma (neutrophilic dermatosesautoantibody interferon-gammaskin findingscytokineschemokinesadhesion moleculesimmunoglobulin (IgG) subclass
- Registration Number
- TCTR20171103001
- Lead Sponsor
- ational Research Management System : NRMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 50
1. age 18-60 years old
2. evidence of Anti-IFN Ƴ autoantibodies by one of these techniques
luciferace immunoprecipitation system (LIPS), anti-IFN Ƴ autoantibody ELISA, particle-based technique, immunobloting technique, modified competitive inhibition assay using Bioplex cytokine assay
3. negative for anti-HIV antibody
4. equal or more than 2 times infects below agents and confirmed by culture, PCR or biopsy
-nontuberculous mycobacterium (NTM)
-disseminated fungal infections (e.g., penicilliosis marneffei, cryptococcosis, histoplasmosis)
-disseminated herpes zoster infection
non-typhoidal Salmonella bacteremia
1.history of cancer
2.using corticosteroids or other immunosuppressive agents within 4 weeks before screening or day that found opportunistic infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical manifestation, opportunistic infection and response to treatment 0 months, 3 months, 6 months, 12 months physical examination,Compare cytokines, chemokines and adhesion molecule between during neutrophilic dermatosis and non 0 months, 3 months, 6 months, 12 months ProcartaPlex® Multiplex Immunoassay Panels ,Relationship of cytokines in serum and skin of neutrophilic dermatoses 0 months, 3 months, 6 months, 12 months polymerase chain reaction (PCR) and immunohistochemistry
- Secondary Outcome Measures
Name Time Method Relationship of autoantibody levels and autoantibody subclasses to IFN-γ with skin manifestation 0 months, 3 months, 6 months, 12 months anti-IFNγ autoantibodies ELISA